• There are no suggestions because the search field is empty.

Regulatory Inspection Readiness: A Proactive Approach to CAPA and Compliance

Author Avatar
Delphine Malisse, Head of Quality Assurance Clinical at QbD Group
Quality Assurance
Clinical
Medical Devices
Pharma & Biotech
Inspection readiness tips: Learn how to manage fallout and improve with CAPA for better regulatory compliance.
Regulatory Inspection Readiness: A Proactive Approach to CAPA and Compliance | QbD Group
3:33

 

“Send” – After weeks of collaboration with the operations team, legal advisors, and experts, a detailed response along with Corrective and Preventive Actions (CAPA) has been submitted to the inspector who visited your site approximately 2 months ago. Unfortunately, clicking “send” doesn’t signify the end of your efforts. If only you had been better prepared…

Inspections by Regulatory Authorities are a standard part of the regulatory framework worldwide. It’s likely that, at some point, an inspector may evaluate your company or services.

What should you expect at the end of an inspection?

 

Immediate Feedback: Your Starting Point

Typically, at the end of an inspection, the inspector will provide feedback highlighting both strengths and areas of deficiency they have identified. 

This feedback is usually given verbally and may be accompanied by an informal written summary. In the U.S., receiving an FDA Form 483 is a sign Usually, at this stage, feedback isn’t graded, but rest assured, the points raised are deemed important and relevant.

 

The Value of Early Analysis and Successful CAPA Building

It is wise to initiate root cause analysis (RCA) and the development of CAPA soon after receiving this informal feedback. A good RCA may require some time, and usually, there is not 1 single root cause that contributed to the finding.

Identifying the primary or significant contributors to the issue is crucial for effective CAPA development. Determining the most appropriate and realistic actions based on these root causes can also be time-consuming. In the end, you’d like to end up with a CAPA that truly supports the organisation; not merely satisfies the inspector (though of course, they need to agree with it 😊).

 

The Trade-off of Time Gained vs. the Possibility of Rework: Why Start Early?

You might wonder why to start RCA and CAPA development before receiving the inspector’s final report. Often, inspectors may take 4 weeks or more to deliver their report but require a response within 2 to 4 weeks.

Starting early, based on initial feedback, can prevent the rush and potential for less thoughtful actions, ensuring your response genuinely supports your organization rather than just meeting perceived expectations.

Starting the process based on informal feedback therefore buys you valuable time, and it will rarely be a useless exercise if the informal feedback focuses on areas that matter in the eyes of the inspector.

After receiving the final report, you may fine-tune your RCA and CAPA as necessary, but complete rework is rarely needed. This approach also allows you to consider new information that may emerge post-inspection.

 

Beyond “Send”: The Importance of Follow-through

Submitting your response does not end the inspection process. Depending on your commitments and organizational structure, improvement teams and CAPA managers might need to ensure these commitments are met and evidence of effectiveness is compiled. Even if not requested, maintaining this evidence is crucial, as inspectors may return.

Throughout these weeks of intense collaboration, amidst stress, negotiations, and more, the question remains: Could I have been better prepared? Could these findings have been avoided?

The answer is yes. Many, if not all, findings could likely have been prevented.

 

Note: This approach is also applicable to audits by certifying/notified bodies or significant internal audits (or for service providers: key client audits).

 

 

Stay ahead in life sciences

Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

Circles-banner-short

Discover more expert content

preview_image
Webinar

From Requirements to Code: a unified MDSW development cycle that covers all requirements

Watch our webinar on demand to master medical device software development. Learn about IEC standards, cybersecurity, AI integration, and FDA expectations.
preview_image
Case study

Ensuring pharmaceutical production quality: cleaning validation for government agency

Discover how QbD Group helped a client tackle dual validation challenges for their production lines, ensuring GMP compliance and AEMPS approval.
preview_image
Webinar

How to manage mandatory communication of Toxicological Risks?

Learn how to effectively manage toxicological risks in the pharmaceutical industry by addressing, reporting, and mitigating potential harm.
preview_image
Webinar

Setting up ATMP Quality Management Systems: Strategies for Compliance and Success

Discover strategies for establishing a compliant and successful ATMP Quality Management System. Watch our webinar on demand.
preview_image
Blog

State Of The Art Literature Review – Process and Documentation

A comprehensive, objective, and thorough systematic literature review to...
preview_image
Blog

The Holy Grail: Achieving Inspection Readiness

In a previous blog post, we talked about the various activities...
preview_image
Blog

What to expect when being inspected?

In a previous blog post “Regulatory Inspection Readiness: A...
preview_image
Blog

Post-Market Success under IVDR: Prioritizing PMS & PMPF

Understanding IVDR requirements To leverage the...